New Study Highlights Scientific Breakthrough in Reduced-Risk Nicotine Delivery
Pneuma Respiratory, a leader in inhaled respiratory therapeutics, today announced the results of a groundbreaking study examining the aerosol composition of various nicotine delivery devices. The study highlights the absence of concerning heavy metals and organic compounds in Pneuma’s innovative, non-heated reduced-risk nicotine delivery system, reinforcing the company’s scientific leadership and commitment to harm reduction.